InvestorsHub Logo
Followers 43
Posts 2488
Boards Moderated 0
Alias Born 10/19/2015

Re: nidan7500 post# 369320

Saturday, 08/06/2022 10:04:14 AM

Saturday, August 06, 2022 10:04:14 AM

Post# of 462040
Valid point. I was lazy but FDA could be swapped out for any other foreign regulatory agency.

My point was more that CEOs of large pharmaceutical companies aren’t going to partner at this stage. They either want to get in early and pay very little, or get in late and pay more when there’s no more risk.

Currently, in the middle of these late stage trials, the cost to partner or acquire Anavex is high but so is the risk. No CEO will jump into that risk/reward scenario with open arms.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News